[1] Mouchli M A, Ouk L, Scheitel M R, et al. Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer. World J Gastroenterol. 2018;24(8):905–916
[2] Zinzani PL, Magagnoli M, Pagliani G, Bendandi M, Gherlinzoni F, Merla E, et al. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Haematologica. 1997;82:305–8
[3] Tahir M, Samad K, Koenig T, Viswanathan P. A rare case of primary diffuse large B-cell lymphoma of the colon. AME Case Rep. 2018, 2:28
[4] Fan CW, Changchien CR, Wang JY, et al. Primary colorectal lymphoma. Dis Colon Rectum. 2000;43:1277–82
[5] Shaye OS, Levine AM. Marginal zone lymphoma. J Natl Compr Cancer Netw, 2006; 4: 311–18
[6] Quayle FJ, Lowney JK. Colorectal lymphoma. Clin Colon Rectal Surg. 2006, 19:49-53
[7] Yoshino T, Ichimura K, Mannami T et al. Multiple organ mucosa-associated lymphoid tissue lymphomas often involve the intestine. Cancer, 2001; 91: 346–53
[8] Ha CS, Cho MJ, Allen PK et al. Primary non-Hodgkin lymphoma of the small bowel. Radiology, 1999; 211: 183–87
[9] Pandey M, Wadhwa MK, Patel DD, Kothari KC. Primary malignant large bowel lymphoma. Am Surg. 2002;68:121–6
[10] Ferreri AJ, Montalban C. Primary diffuse large B-cell lymphoma of the stomach. Crit Rev Oncol Hematol, 2007; 63: 65–71
[11] Zhai L, Zhao Y, Lin L, Tian Y, Chen X, Huang H, Lin T. Non-Hodgkin’s lymphoma involving the ileocecal region: a single-institution analysis of 46 cases in a Chinese population. J Clin Gastroenterol. 2012;46(6):50914
[12] Busch E, Rodriguez-Bigas M, Mamounas E, Barcos M, Petrelli NJ. Primary colorectal non-Hodgkin’s lymphoma. Ann Surg Oncol. 1994;1:222–8
[13] She WH, Day W, Lau PY, Mak KL, Yip AW. Primary colorectal lymphoma: case series and literature review. Asian J Surg. 2011;34(3):111–4
[14] Matsumoto T, Iida M, Shimizu M. Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet, 1997; 350: 115–16
[15] Nakamura S, Yao T, Aoyagi K et al. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer, 1997; 79(1): 3–11
[16] Zhou JL, Qiu HZ, Sun J, Li J. The diagnosis and treatment of colorectal non-Hodgkin’s lymphoma 32 cases. Zhonghua Wai Ke Za Zhi. 2011;49(4):290–4
[17] She WH, Day W, Lau PY, Mak KL, Yip AW. Primary colorectal lymphoma: case series and literature review. Asian J Surg. 2011;34(3):111–4
[18] Tevlin R, Larkin JO, Hyland JM, O’Connell PR, Winter DC 2. Primary colorectal lymphoma - a single centre experience. Surgeon. 2015;13(3):151–155.
[19] Bairey O, Ruchlemer R, Shpilberg O. Non-Hodgkin’s lymphomas of the colon. Isr Med Assoc J. 2006;8:832–5.
[20] Li B, Shi YK, He XH et al. Primary non-Hodgkin lymphomas in the small and large intestine: Clinicopathological characteristics and management of 40 patients. Int J Hematol, 2008; 87: 375–81
[21] Pfreundschuh M, Kuhnt E, Trümper L, et al. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol. 2011, 12:1013-1022
[22] Hammel P, Haioun C, Chaumette MT et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol, 1995; 13: 2524–29
[23] Salar A, Domingo-Domenech E, Estany C, Canales MA, Gallardo F, Servitje O, et al. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer. 2009;115:5210–7
[24] Raderer M, Jager G, Brugger S et al. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology, 2003; 65: 306–10
[25] Koniaris LG, Drugas G, Katzman PJ, Salloum R. Management of gastrointestinal lymphoma. J Am Coll Surg, 2003; 197: 127–41
[26] Cai S, Cannizzo F Jr, Bullard Dunn KM, Gibbs JF, CzuczmanM RA. The role of surgical intervention in non-Hodgkin’s lymphoma of the colon and rectum. Am J Surg. 2007;193:409–12
[27] Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer, 1972; 29: 252–60
[28] Morrison VA. Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma. Expert Rev Anticancer Ther. 2008;8:1651–8